Overview

As of January 2014, the EMA lifted the restriction on providing fee reductions to large companies developing new orphan drugs and the Early Access to Medicines Scheme was introduced. Key implementation of this will be a factor into further commercialisation and developments.

Based on this information, SMi Group is proud to announce it will be hosting the 3rd annual conference on Orphan Drugs and Rare Diseases and bringing together leading experts and companies such as Pfizer, AstraZeneca, GMP Orphan SAS, Genethon, M&C Saatchi and Novabiotics and many more to discuss the latest developments in the market



Venue: Holiday Inn Regents Park Hotel
Location: Carburton Street, London
Country: United Kingdom

Organiser Contact Details:
SMi Group
T: +4402078276184
swatson@smi-online.co.uk